Affimed (AFMD) Misses Q2 EPS by 2c

Affimed (NASDAQ: AFMD) reported Q2 EPS of (EUR0.19), EUR0.02 worse than the analyst estimate of (EUR0.17). Revenue for the quarter came in at EUR2.2 million versus the consensus estimate of EUR2.57 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c